Programmed death-ligand 1 (PD-L1) is expressed on cancer cells and binds to programmed cell death-1 (PD-1) on immune cells, resulting in an immunosuppressive signal that inhibits lymphocyte activation. This evidence concerns the gene CD274 and cancer.